Shield Therapeutics Share Discussion Threads

[78steve] 04/5/2020 12:20

Tried dummy trade they're making it hard to sell even tiny amounts but can buy easily suggesting not that much demand for shares.

[peachie 74] 04/5/2020 10:26

Edison have just issued new raised valuation price..£3.15

[peachie 74] 03/5/2020 22:59

They don’t. It was stated that the H2H was not used in US or China

[daveboy1] 03/5/2020 22:32

Hopefully they don’t have to hand any of that back. Wondering if 23rd June needs to pass before any deal can/will be announced...

[peachie 74] 03/5/2020 20:03

Should be. The company is in a far better position now... ASK millions for starters

[78steve] 03/5/2020 18:20

This was at 180-200p after FDA approval and so presumably the the price will recover to that level on expectation of US deal and as FDA approval still stands .Then when deal announced who knows 250p ? Pure guess anything possible as has been seen recently

[peachie 74] 02/5/2020 10:31

In accordance with AIM Rule 26, in so far as the Company is aware as at 14th April 2020, the percentage of the Company’s issued share capital that is not in public hands is 68%.

I forgot just how few shares are in PI hands..32%. And by the look of recent events, strong holders too that are looking long term. That ridiculous mark down on Friday shows we have strong holders who know the prospects here. No wonder the price starts rising quick on low volume, no one giving up their shares

[best1467] 02/5/2020 08:42

Great work on the numbers Shield are responsible for manufacture costs but not sure what the margin comes out at Which would give the actual bottom line on the £70 million revenue but a substantial number even up to 2021 just need the USA deal ASAP .
Agree with Steve the big mark down yesterday at the bell was fake it wasn’t tradable amazing how it’s legal but we have seen some unbelievable trading especially Friday in a number of stocks

[peachie 74] 01/5/2020 19:15

Our contract manufacturing partners continue to manufacture Feraccru (R) for us without disruption. We rely on a UK company to manufacture ferric maltol, the active pharmaceutical ingredient (API) in Feraccru (R) , and a French company to convert the API into finished packs. Our UK manufacturer is currently working on a campaign to manufacture around 12.5 metric tonnes of ferric maltol which should be completed by the end of September 2020. This will provide us with sufficient API to last throughout 2021. Our French manufacturer is also continuing to manufacture finished packs for sale by Norgine and AOP in Europe, and we have also placed orders for launch supplies of US packs so that we will be in a position to supply US packs promptly when we have secured a US commercial partner.

This actually is a very encouraging. "The UK manufacture of ferric maltol is currently working on a campaign manufacture 12.5 tonnes".....they have to be under instruction from Shield , they will not be producing unnecessarily..so Shield must have a feel for what is needed. And you would think this is also a minimum, you would not want to over produce.

Can we presume this figure does not include ferric maltol demand that will come from the US also ?
Oh and then there will be China and Hong Kong in future...

OK , now I'm getting excited !

[peachie 74] 01/5/2020 19:03

Ha thanks. It was me reporting someone else's hard work TBF

Great looking figures though.

[crankyman] 01/5/2020 18:37

It does suggest a hell of a lot of demand for stock. I presume that’s why they reported it. Otherwise it’s an odd thing to report.

[montyhedge] 01/5/2020 17:59

Good work peachie.

[peachie 74] 01/5/2020 17:03

From LSE ....

12.5 metric tonnes of ferric maltol ( in RNS) equates to ....


7.4m bottles of 56 caps at 30mg each. A lot. If you guess a 20% royalty on gross revenue and a UK list price of £47.60 in all markets that is £70m from that one order of API. If anyone gets a different number I'd like to see if that is right or not. Not insignificant!

And that’s just for starters.

[peachie 74] 01/5/2020 15:22

Good points Cranky

[crankyman] 01/5/2020 15:18

There’s no way the H2H review comes out any differently than what we already know and something a little worse. It’s not going to resolve it. Anyway the H2H is still a good basis for pricing as even accounting for some patients not complying with oral, those patients just go on to get an IV. So from an outcomes perspective it will be the same for both arms but the cost of the oral arm is hugely lower. Added to that the benefit patients that don’t want to take IV because it means getting sick enough to need it. Like I said, Norgine are freakin’ hopeless if they don’t get this product priced.

[peachie 74] 01/5/2020 14:52

Cheers Nobby.
A lot of H2H still applicable though. And wasn’t it just on GI related Iron deficiency ?
Anyway. The deal will be good. We know that much.
Can sell a lot online. Can only get a price for a 1000 at 120 .....

[nobbygnome] 01/5/2020 14:38

Well you have to think the HtoH fiasco will affect the upfront and the milestones etc. I know it's not on the label in the US currently but the plan would have been to submit the data at the earliest opportunity. Around here $50 million upfront was being suggested so I will go for $30-40 million upfront.

[peachie 74] 01/5/2020 14:21

What they did first thing should be on Crimewatch !

Any ideas people , how many millions will be involved in US deal.

BTW I wonder if Norgine will give the money back if the H2H shown to be valid. RNS did say a lot of it all still applicable

[montyhedge] 01/5/2020 13:34

Market makers are professional pick pockets.

[nobbygnome] 01/5/2020 12:51

Very wide spread putting off trading. Come on, make a proper market FFS!

[peachie 74] 01/5/2020 12:49

And that market cap will look nothing when the US deal comes through.

[78steve] 01/5/2020 12:33

Company loses 2m so should be down around 2% on the day due to mcap around 100m

[78steve] 01/5/2020 11:52

Great opportunity for top ups now. Got some more around 112 will add more further down it goes. Dyor

[montyhedge] 01/5/2020 09:30

Market makers shaking the tree, see which weak holders fall out.

[peachie 74] 01/5/2020 09:23

Well, I think the MMs thought they could scare a few sales. Thats not happened and no real reason why it should. The company is still very much undervalued IMO